Literature DB >> 29494148

Structure-Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists.

Fabio A Facchini1, Lenny Zaffaroni1, Alberto Minotti1, Silvia Rapisarda1, Valentina Calabrese1, Matilde Forcella1, Paola Fusi1, Cristina Airoldi1, Carlotta Ciaramelli1, Jean-Marc Billod2, Andra B Schromm3, Harald Braun4, Charys Palmer5, Rudi Beyaert4, Fabio Lapenta6, Roman Jerala6, Grisha Pirianov5, Sonsoles Martin-Santamaria2, Francesco Peri1.   

Abstract

The structure-activity relationship was investigated in a series of synthetic TLR4 antagonists formed by a glucosamine core linked to two phosphate esters and two linear carbon chains. Molecular modeling showed that the compounds with 10, 12, and 14 carbons chains are associated with higher stabilization of the MD-2/TLR4 antagonist conformation than in the case of the C16 variant. Binding experiments with human MD-2 showed that the C12 and C14 variants have higher affinity than C10, while the C16 variant did not interact with the protein. The molecules, with the exception of the C16 variant, inhibited the LPS-stimulated TLR4 signal in human and murine cells, and the antagonist potency mirrored the MD-2 affinity calculated from in vitro binding experiments. Fourier-transform infrared, nuclear magnetic resonance, and small angle X-ray scattering measurements suggested that the aggregation state in aqueous solution depends on fatty acid chain lengths and that this property can influence TLR4 activity in this series of compounds.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29494148     DOI: 10.1021/acs.jmedchem.7b01803

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

1.  Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis.

Authors:  Fabio Alessandro Facchini; Davide Di Fusco; Simona Barresi; Andrea Luraghi; Alberto Minotti; Francesca Granucci; Giovanni Monteleone; Francesco Peri; Ivan Monteleone
Journal:  Eur J Clin Pharmacol       Date:  2020-01-25       Impact factor: 2.953

2.  Deep-sea microbes as tools to refine the rules of innate immune pattern recognition.

Authors:  Anna E Gauthier; Courtney E Chandler; Valentina Poli; Francesca M Gardner; Aranteiti Tekiau; Richard Smith; Kevin S Bonham; Erik E Cordes; Timothy M Shank; Ivan Zanoni; David R Goodlett; Steven J Biller; Robert K Ernst; Randi D Rotjan; Jonathan C Kagan
Journal:  Sci Immunol       Date:  2021-03-12

3.  Biochemical and Functional Analysis of Cyanobacterium Geitlerinema sp. LPS on Human Monocytes.

Authors:  Michelle Swanson-Mungerson; Philip Williams; Joshua R Gurr; Ryan Incrocci; Vijay Subramaniam; Kinga Radowska; Mary L Hall; Alejandro M S Mayer
Journal:  Toxicol Sci       Date:  2019-07-04       Impact factor: 4.109

4.  Bradyrhizobium Lipid A: Immunological Properties and Molecular Basis of Its Binding to the Myeloid Differentiation Protein-2/Toll-Like Receptor 4 Complex.

Authors:  Luigi Lembo-Fazio; Jean-Marc Billod; Flaviana Di Lorenzo; Ida Paciello; Mateusz Pallach; Sara Vaz-Francisco; Aurora Holgado; Rudi Beyaert; Manuel Fresno; Atsushi Shimoyama; Rosa Lanzetta; Koichi Fukase; Djamel Gully; Eric Giraud; Sonsoles Martín-Santamaría; Maria-Lina Bernardini; Alba Silipo
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

5.  A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages.

Authors:  Yanxian Feng; Ruoyu Mu; Zhenzhen Wang; Panfei Xing; Junfeng Zhang; Lei Dong; Chunming Wang
Journal:  Nat Commun       Date:  2019-05-22       Impact factor: 14.919

6.  Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties.

Authors:  Florent Cochet; Fabio A Facchini; Lenny Zaffaroni; Jean-Marc Billod; Helena Coelho; Aurora Holgado; Harald Braun; Rudi Beyaert; Roman Jerala; Jesus Jimenez-Barbero; Sonsoles Martin-Santamaria; Francesco Peri
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

Review 7.  Glycoconjugates of Gram-negative bacteria and parasitic protozoa - are they similar in orchestrating the innate immune response?

Authors:  Magdalena A Karaś; Anna Turska-Szewczuk; Monika Janczarek; Agnieszka Szuster-Ciesielska
Journal:  Innate Immun       Date:  2019-01       Impact factor: 2.680

Review 8.  Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview.

Authors:  Alessio Romerio; Francesco Peri
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561

9.  Homeostatic and pathogenic roles of GM3 ganglioside molecular species in TLR4 signaling in obesity.

Authors:  Hirotaka Kanoh; Takahiro Nitta; Shinji Go; Kei-Ichiro Inamori; Lucas Veillon; Wataru Nihei; Mayu Fujii; Kazuya Kabayama; Atsushi Shimoyama; Koichi Fukase; Umeharu Ohto; Toshiyuki Shimizu; Taku Watanabe; Hiroki Shindo; Sorama Aoki; Kenichi Sato; Mika Nagasaki; Yutaka Yatomi; Naoko Komura; Hiromune Ando; Hideharu Ishida; Makoto Kiso; Yoshihiro Natori; Yuichi Yoshimura; Asia Zonca; Anna Cattaneo; Marilena Letizia; Maria Ciampa; Laura Mauri; Alessandro Prinetti; Sandro Sonnino; Akemi Suzuki; Jin-Ichi Inokuchi
Journal:  EMBO J       Date:  2020-05-07       Impact factor: 11.598

10.  The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling.

Authors:  Charys Palmer; Francesco Peri; Frank Neumann; Feroz Ahmad; David S Leake; Grisha Pirianov
Journal:  Innate Immun       Date:  2018-09-12       Impact factor: 2.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.